COMMUNIQUÉS West-GlobeNewswire

Park Dental Partners Announces First Quarter 2026 Results
13/05/2026
MINNEAPOLIS, May 13, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its first-quarter [...]
Combined General Meeting of June 3, 2026
13/05/2026
Châtillon, France, May 13, 2026 Combined General Meeting of June 3, 2026 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: [...]
Assemblée Générale Mixte du 3 juin 2026
13/05/2026
Châtillon, France, le 13 mai 2026 Assemblée Générale Mixte du 3 juin 2026 Modalités de mise à disposition des informations et documents préparatoires à l’Assemblée Générale Mixte DBV Technologies (Euronext : DBV – ISIN [...]
EDAP | Focal One to Host Investor Day on June 1, 2026
13/05/2026
AUSTIN, Texas, May 13, 2026 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic energy-based therapies, today announced that it will host an Investor Day for analysts and investors at 8:00 am ET [...]
Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
13/05/2026
Reports first quarter 2026 total revenue of $8.0 million , representing 11% growth compared to the first quarter of 2025 Placed 6 Growth Direct systems in the first quarter 2026 compared to 3 systems in the first [...]
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
13/05/2026
First clinical data from PRMT5/RAS(ON) combination trial to be pre sented in 2026 Cash position of $380 million as of March 31, 2026, with runway into 2028 beyond anticipated key data inflection points BOSTON, May 13, [...]
Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
13/05/2026
CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today [...]
SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates
13/05/2026
Added 7 top-rated children’s hospitals to QUELIMMUNE ® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue Advanced enrollment in the NEUTRALIZE-AKI [...]
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
13/05/2026
SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as [...]
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
13/05/2026
Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026 $28 million in cash, cash equivalents, restricted cash [...]
Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress
13/05/2026
Received initial purchase orders for recombinant bovine transferrin from customers in the cultivated meat industry Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using [...]
Bionano Reports First Quarter 2026 Results and Provides a Business Update
13/05/2026
Conference call today, May 13, 2026, at 4:30 PM ET SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The [...]
LogicMark, Inc. Announces Strong First Quarter 2026 Results
13/05/2026
Revenue Up 24% as Gross Margin Expands to 69.6% and Operating Loss Narrows LOUISVILLE, Ky., May 13, 2026 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK) (the “Company”), a provider of personal safety and emergency [...]
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
13/05/2026
Progressing toward commercialization with third-party head-to-head data publications and GALACTIC registry study engagement Northeast kidney transplant center (among the top 10 in the U.S.) is first to sign clinical [...]
Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
13/05/2026
100% insulin independence achieved in 10 patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led study FDA Orphan Drug designation granted to tegoprubart for the [...]
Glass House Brands Reports First Quarter 2026 Financial Results
13/05/2026
First quarter results include revenue of $40.5 million, average selling price of $171 per pound and biomass production of 152,000 pounds Company reiterates full year 2026 wholesale cannabis biomass production forecast [...]
Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
13/05/2026
REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for [...]
Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
13/05/2026
New Drug Application (NDA) for tebipenem HBr for complicated urinary tract infections (cUTI), including pyelonephritis, is under review at the FDA, with PDUFA date of June 18, 2026 Spero maintains its cash runway [...]
Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update
13/05/2026
On track for August 2026 top-line results from Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for hypoplastic left heart syndrome, a rare pediatric disease and orphan- [...]

Pages